SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AVII - AVI BioPharma (Cancer Vaccine)
An SI Board Since July 1999
Posts SubjectMarks Bans
284 16 0
Emcee:  StockMiser Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
34Oral delivery seems to be safe for third generation antisense based drugs. biz.yDELT1970-11/9/2000
33Dr. Burger's remarks in the latter half of the Call on the potential value oDELT1970-11/8/2000
32AVI has scheduled an investor conference call regarding this announcement to be Jim Oravetz-11/7/2000
31AVI BioPharma, Inc. (Nasdaq:AVII), announced today its selection of the Texas CaJim Oravetz-10/27/2000
30AVI BioPharma Presents Cancer Vaccine and Antisense Clinical Development Update DELT1970-10/19/2000
29AVI BioPharma Presents At Eighth Annual BioPartnering Europe Conference PORTLAJim Oravetz-10/17/2000
28Apparently report was based on a CYTO/PGNX collaboration, which dervies from a lgreedsgd_2000-9/5/2000
27DATELINE story tonight on cancer vaccines - its not AVii, as they are enrolling greedsgd_2000-9/3/2000
26Role of c-myc oncogene in control of apoptosis c-myc, a proto-oncogene whose dysJim Oravetz-9/1/2000
25Looks like a 5 bagger here: at radiowallstreet.com 8-15-00 conf call with CEO egreedsgd_2000-8/28/2000
24Slightly Off Topic Check this out, if you can: vistaafter5.comOLD JAKE JUSTUS-8/16/2000
23Telomerase linked with cancer risk? New findings suggest that the use of telomeJim Oravetz-8/16/2000
22"The Financing Risk Has Been Removed From The Company," stated CEO, DrDELT1970-8/15/2000
21A 3 million share secondary offering was completed today at $7.25, well below thDELT1970-7/27/2000
20 $850K In Grants For Antisense Applications. biz.yahoo.comDELT1970-6/27/2000
19 Compound adds to inventory of AVI-licensed technologies that show potential in Jim Oravetz-6/7/2000
18 (continued) EASI report, More Milestone Target Dates Resten-NG End Phase I toxDELT1970-6/3/2000
17 From EASI research report, Appendix 1, Potential Milestone Target Dates: AviciDELT1970-6/3/2000
16 From the 28 April 2000 research report by European American Securities with theDELT1970-6/3/2000
15 I hope the media covers the special session on cancer vaccines and hears our orDELT1970-5/19/2000
14 PORTLAND, Ore.--(BW HealthWire)--May 19, 2000--Patrick L. Iversen, Ph.D., SenioJim Oravetz-5/19/2000
13 New AVII Patent Issued -- 5/9/2000 by: bc_mack (35/M/Dallas, TX) bc_mack-5/15/2000
12 At the annual meeting May 11, the CEO announced that a new institutional researDELT1970-5/13/2000
11 SUPG invests more in AVII's cancer vaccine. AVII retains share of profits aDELT1970-4/5/2000
10 Cancer is expected to surpass heart disease in the coming decade as the leadingDELT1970-2/8/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News